Daniel Klass
- Director at Docebo
Bio
Buyout and Growth Equity focused on enterprise SaaS businesses. Portfolio includes www.methodcrm.com www.360incentives.com www.dealer.com www.venasolutions.com www.firmex.com www.unoapp.com www.nulogy.com www.granify.com www.resolver.com www.alayacare.com www.tracktik.com www.bigroad.com www.condocontrolcentral.com www.docebo.com www.optimy.com. Specialties Software Buyout